Expanded Access to Mepsevii
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
AgeNot listed
SponsorUltragenyx Pharmaceutical Inc
About this trial
Individual patient expanded access requests may be considered for patients who have no other treatment options
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
None
Trial design
Treatments tested in this trial
Mepsevii
Drug
Treatment groups
No treatment groups listed
Trial outcomes
This trial has no outcomes listed.Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov